Related references
Note: Only part of the references are listed.Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients
Regina Dutkowski
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
Brian E. Davies
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Is oseltamivir (Tamiflu®) safe? Re-examining the Tamiflu 'ado' from Japan
Etsuji Okamoto
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis
Toshiyuki Harada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Thrombocytopenia from Combination Treatment with Oseltamivir and Probenecid: Case Report, MedWatch Data Summary, and Review of the Literature
Dennis W. Raisch et al.
PHARMACOTHERAPY (2009)
Oseltamivir, an anti-influenza virus drug, produces hypothermia in mice: Comparison among Oseltamivir, Zanamivir and Diclofenac
Hideki Ono et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Oseltamivir's adverse reactions - Fifty sudden deaths may be related to central suppression
Rokuro Hama
BMJ-BRITISH MEDICAL JOURNAL (2007)
Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel
Deshi Shi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Prevention and treatment of influenza in high-risk groups: Children, pregnant women, inununocompromised hosts, and nursing home residents
Richard J. Whitley et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Species-, sex-, and age-dependent urinary excretion of cauxin, a mammalian carboxylesterase
Masao Miyazaki et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2006)
Safety and pharmacology of oseltamivir in clinical use
R Dutkowski et al.
DRUG SAFETY (2003)
Carboxyl ester lipase: structure-function relationship and physiological role in lipoprotein metabolism and atherosclerosis
DY Hui et al.
JOURNAL OF LIPID RESEARCH (2002)
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion - Correlation of in vivo and in vitro studies
G Hill et al.
DRUG METABOLISM AND DISPOSITION (2002)
Oseltamivir - A review of its use in influenza
K McClellan et al.
DRUGS (2001)
Influenza virus neuraminidase inhibitors
LV Gubareva et al.
LANCET (2000)
Share Paper
